Pharmacogenomics, genetic testing and ethnic variability: tackling the ethical questions.

about

Motivations of Patients with Diabetes to Participate in Research Personalized psychiatry: a realistic goal.Pharmacogenomics education: International Society of Pharmacogenomics recommendations for medical, pharmaceutical, and health schools deans of education.

P2860

Q34539691-6991A708-C47A-44D0-8F03-1DC593BDE70E Q35689150-0C87F361-F357-4CBF-A292-132DB0C635EE Q47618340-BF1A9ACE-D4BF-4653-A47A-EB09EE488122

P2860

Pharmacogenomics, genetic testing and ethnic variability: tackling the ethical questions.

Item

http://www.wikidata.org/entity/Q47661304

description

2003 nî lūn-bûn

@nan

2003年の論文

@ja

2003年学术文章

@wuu

2003年学术文章

@zh-cn

2003年学术文章

@zh-hans

2003年学术文章

@zh-my

2003年学术文章

@zh-sg

2003年學術文章

@yue

2003年學術文章

@zh

2003年學術文章

@zh-hant

name

Pharmacogenomics, genetic testing and ethnic variability: tackling the ethical questions.

@en

Pharmacogenomics, genetic testing and ethnic variability: tackling the ethical questions.

@nl

type

Item

label

Pharmacogenomics, genetic testing and ethnic variability: tackling the ethical questions.

@en

Pharmacogenomics, genetic testing and ethnic variability: tackling the ethical questions.

@nl

prefLabel

Pharmacogenomics, genetic testing and ethnic variability: tackling the ethical questions.

@en

Pharmacogenomics, genetic testing and ethnic variability: tackling the ethical questions.

@nl

P1476

Pharmacogenomics, genetic testing and ethnic variability: tackling the ethical questions.

@en

P2093

Bernhard R Winkelmann

http://www.w3.org/2001/XMLSchema#string

P2860

Population genetic structure of variable drug response

Lesser response to angiotensin-converting-enzyme inhibitor therapy in black as compared with white patients with left ventricular dysfunction

Principles, organization, and operation of a DNA bank for clinical trials: a Department of Veterans Affairs cooperative study.

Rationale and design of the LURIC study--a resource for functional genomics, pharmacogenomics and long-term prognosis of cardiovascular disease.

Molecular basis of ethnic differences in drug disposition and response.

DNA banking for epidemiologic studies: a review of current practices.

Pharmacogenetics in diverse ethnic populations--implications for drug discovery and development.

Ethical, legal, and social implications of genomic medicine.

Race and the response to adrenergic blockade with carvedilol in patients with chronic heart failure.

"Genetic exceptionalism" in medicine: clarifying the differences between genetic and nongenetic tests.

P304

531-535

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1517/PHGS.4.5.531.23801

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2003-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

12943462

http://www.w3.org/2001/XMLSchema#string

P921

pharmacogenomics

Pharmacogenomics, genetic testing and ethnic variability: tackling the ethical questions.

about

P2860

P2860

Pharmacogenomics, genetic testing and ethnic variability: tackling the ethical questions.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921